Home-grown firm submits its Alzheimer's drug for FDA approval

Yale-NUS College's Assistant Professor Jan Gruber and research fellow Emelyne Teo with a magnified image of the tiny worm called Caenorhabditis elegans. The researchers worked with the worms, which share many similarities with humans at the molecular level, to find a way to fight Alzheimer's disease. ST PHOTO: KELVIN CHNG
New: Gift this subscriber-only story to your friends and family

At least 30 people with Alzheimer's disease in Singapore have tried an experimental drug, developed by a local firm, that is said to slow down progression of the brain disorder.

Currently, drugs on the market treat only the symptoms without affecting the course of the disease.

Already a subscriber? 

Read the full story and more at $9.90/month

Get exclusive reports and insights with more than 500 subscriber-only articles every month

Unlock these benefits

  • All subscriber-only content on ST app and straitstimes.com

  • Easy access any time via ST app on 1 mobile device

  • E-paper with 2-week archive so you won't miss out on content that matters to you

Join ST's WhatsApp Channel and get the latest news and must-reads.

A version of this article appeared in the print edition of The Straits Times on July 01, 2020, with the headline Home-grown firm submits its Alzheimer's drug for FDA approval. Subscribe